Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
34723 | 107 | 35.5 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
2641 | 2 | EPITHELIAL MESENCHYMAL TRANSITION//EMT//SNAIL | 3501 |
34723 | 1 | CSE1L//PHOSPHO CSE1L//CELLULAR APOPTOSIS SUSCEPTIBILITY | 107 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CSE1L | authKW | 3495896 | 13% | 88% | 14 |
2 | PHOSPHO CSE1L | authKW | 570759 | 2% | 100% | 2 |
3 | CELLULAR APOPTOSIS SUSCEPTIBILITY | authKW | 380505 | 2% | 67% | 2 |
4 | 10Q23 GENETIC LOCUS | authKW | 285380 | 1% | 100% | 1 |
5 | ALLERGY IMMUNOL RHEUMATOLCHANG GUNG MEM HO | address | 285380 | 1% | 100% | 1 |
6 | ANIM HUSB ANIM WEALTH | address | 285380 | 1% | 100% | 1 |
7 | CAS CELLULAR APOPTOSIS SUSCEPTIBILITY GENE | authKW | 285380 | 1% | 100% | 1 |
8 | CELLULAR APOPTOSIS SUSCEPTIBILITY CAS PROTEIN | authKW | 285380 | 1% | 100% | 1 |
9 | CELLULAR APOPTOSIS SUSCEPTIBILITY CSE1L CAS PROTEIN | authKW | 285380 | 1% | 100% | 1 |
10 | CELLULAR APOPTOSIS SUSCEPTIBILITY GENE | authKW | 285380 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pathology | 282 | 15% | 0% | 16 |
2 | Oncology | 270 | 27% | 0% | 29 |
3 | Biochemistry & Molecular Biology | 134 | 32% | 0% | 34 |
4 | Cell Biology | 122 | 19% | 0% | 20 |
5 | Medicine, Research & Experimental | 96 | 12% | 0% | 13 |
6 | Developmental Biology | 16 | 3% | 0% | 3 |
7 | Biology | 12 | 4% | 0% | 4 |
8 | Genetics & Heredity | 6 | 5% | 0% | 5 |
9 | Biophysics | 5 | 4% | 0% | 4 |
10 | Obstetrics & Gynecology | 5 | 3% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALLERGY IMMUNOL RHEUMATOLCHANG GUNG MEM HO | 285380 | 1% | 100% | 1 |
2 | ANIM HUSB ANIM WEALTH | 285380 | 1% | 100% | 1 |
3 | CELLULAR ORGNISM BIOL | 285380 | 1% | 100% | 1 |
4 | CHEM TOXIC PESTICIDES | 285380 | 1% | 100% | 1 |
5 | FI BIOINGN | 285380 | 1% | 100% | 1 |
6 | ONCOL SCIIRCC | 285380 | 1% | 100% | 1 |
7 | SHENZHEN SUPERHYBRID RIC | 285380 | 1% | 100% | 1 |
8 | GERMAN TRANSLAT CANC DKTK | 142689 | 1% | 50% | 1 |
9 | PROTE TRANSLAT | 142689 | 1% | 50% | 1 |
10 | TUMOR GENET UNIT | 95125 | 1% | 33% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UKRAINSKII BIOKHIMICHESKII ZHURNAL | 8898 | 6% | 1% | 6 |
2 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2733 | 5% | 0% | 5 |
3 | ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY | 1726 | 3% | 0% | 3 |
4 | ONCOLOGY RESEARCH AND TREATMENT | 1144 | 1% | 0% | 1 |
5 | JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY | 891 | 2% | 0% | 2 |
6 | MOLECULAR MEDICINE | 734 | 2% | 0% | 2 |
7 | POLISH JOURNAL OF PATHOLOGY | 701 | 1% | 0% | 1 |
8 | BIOSCIENCE TRENDS | 616 | 1% | 0% | 1 |
9 | BIOCELL | 610 | 1% | 0% | 1 |
10 | CELLULAR ONCOLOGY | 603 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHAN, C , ZHANG, XY , PANG, D , (2016) HIGH EXPRESSION OF CSE1L IS ASSOCIATED WITH POOR PROGNOSIS IN BREAST CANCER.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. VOL. 9. ISSUE 11. P. 11788 -11794 | 26 | 90% | 0 |
2 | JIANG, MC , (2016) CAS (CSE1L) SIGNALING PATHWAY IN TUMOR PROGRESSION AND ITS POTENTIAL AS A BIOMARKER AND TARGET FOR TARGETED THERAPY.TUMOR BIOLOGY. VOL. 37. ISSUE 10. P. 13077 -13090 | 51 | 38% | 0 |
3 | YUKSEL, UM , TURKER, I , DILEK, G , DOGAN, L , GULCELIK, MA , OKSUZOGLU, B , (2015) DOES CSE1L OVEREXPRESSION AFFECT DISTANT METASTASIS DEVELOPMENT IN BREAST CANCER?.ONCOLOGY RESEARCH AND TREATMENT. VOL. 38. ISSUE 9. P. 431 -434 | 20 | 87% | 2 |
4 | YUKSEL, UM , DILEK, G , DOGAN, L , GULCELIK, MA , BERBEROGLU, U , (2015) THE RELATIONSHIP BETWEEN CSE1L EXPRESSION AND AXILLARY LYMPH NODE METASTASIS IN BREAST CANCER.TUMORI. VOL. 101. ISSUE 2. P. 194 -198 | 18 | 82% | 1 |
5 | TAI, CJ , HSU, CH , SHEN, SC , LEE, WR , JIANG, MC , (2010) CELLULAR APOPTOSIS SUSCEPTIBILITY (CSE1L/CAS) PROTEIN IN CANCER METASTASIS AND CHEMOTHERAPEUTIC DRUG-INDUCED APOPTOSIS.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 29. ISSUE . P. - | 33 | 40% | 11 |
6 | TAI, CJ , SU, TC , JIANG, MC , CHEN, HC , SHEN, SC , LEE, WR , LIAO, CF , CHEN, YC , LIN, SH , LI, LT , ET AL (2013) CORRELATIONS BETWEEN CYTOPLASMIC CSE1L IN NEOPLASTIC COLORECTAL GLANDS AND DEPTH OF TUMOR PENETRATION AND CANCER STAGE.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 11. ISSUE . P. - | 19 | 50% | 4 |
7 | LIAO, CF , LUO, SF , LI, LT , LIN, CY , CHEN, YC , JIANG, MC , (2008) CSEIL/CAS, THE CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN, ENHANCES INVASION AND METASTASIS BUT NOT PROLIFERATION OF CANCER CELLS.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 27. ISSUE . P. - | 19 | 56% | 15 |
8 | CHANG, CC , TAI, CJ , SU, TC , SHEN, KH , LIN, SH , YEH, CM , YEH, KT , LIN, YM , JIANG, MC , (2012) THE PROGNOSTIC SIGNIFICANCE OF NUCLEAR CSE1L IN URINARY BLADDER UROTHELIAL CARCINOMAS.ANNALS OF DIAGNOSTIC PATHOLOGY. VOL. 16. ISSUE 5. P. 362-368 | 17 | 52% | 4 |
9 | JIANG, MC , YEH, CM , TAI, CJ , CHEN, HC , LIN, SH , SU, TC , SHEN, SC , LEE, WR , LIAO, CF , LI, LT , ET AL (2013) CSE1L MODULATES RAS-INDUCED CANCER CELL INVASION: CORRELATION OF K-RAS MUTATION AND CSE1L EXPRESSION IN COLORECTAL CANCER PROGRESSION.AMERICAN JOURNAL OF SURGERY. VOL. 206. ISSUE 3. P. 418-427 | 18 | 44% | 3 |
10 | HOLZER, K , DRUCKER, E , OLIVER, S , WINKLER, J , EITENEUER, E , HERPEL, E , BREUHAHN, K , SINGER, S , (2016) CELLULAR APOPTOSIS SUSCEPTIBILITY (CAS) IS OVEREXPRESSED IN THYROID CARCINOMA AND MAINTAINS TUMOR CELL GROWTH: A POTENTIAL LINK TO THE BRAF(V600E) MUTATION.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 48. ISSUE 4. P. 1679 -1687 | 14 | 45% | 2 |
Classes with closest relation at Level 1 |